GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Other Operating Expense

Cardia Bioplastics (ASX:CNN) Other Operating Expense : A$2.08 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Other Operating Expense?

Cardia Bioplastics's Other Operating Expense for the six months ended in Dec. 2023 was A$0.99 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$2.08 Mil.

Cardia Bioplastics's quarterly Other Operating Expense increased from Dec. 2022 (A$1.00 Mil) to Jun. 2023 (A$1.10 Mil) but then declined from Jun. 2023 (A$1.10 Mil) to Dec. 2023 (A$0.99 Mil).

Cardia Bioplastics's annual Other Operating Expense increased from Jun. 2021 (A$1.36 Mil) to Jun. 2022 (A$1.82 Mil) and increased from Jun. 2022 (A$1.82 Mil) to Jun. 2023 (A$2.09 Mil).


Cardia Bioplastics Other Operating Expense Historical Data

The historical data trend for Cardia Bioplastics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Other Operating Expense Chart

Cardia Bioplastics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 1.69 1.36 1.82 2.09

Cardia Bioplastics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.95 1.00 1.10 0.99

Cardia Bioplastics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardia Bioplastics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardia Bioplastics (ASX:CNN) Business Description

Traded in Other Exchanges
Address
247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149
SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines